The role of inflammation in depression: from evolutionary imperative to modern treatment target
By Andrew H. Miller, Charles L Raison. Nature reviews. Immunology, 2015
3,447 citations recorded by the source corpus.
Crosstalk between inflammatory pathways and neurocircuits in the brain can lead to behavioural responses, such as avoidance and alarm, that are likely to have provided early humans with an evolutionary advantage in their interactions with pathogens and predators. However, in modern times, such interactions between inflammation and the brain appear to drive the development of depression and may contribute to non-responsiveness to current antidepressant therapies. Recent data have elucidated the mechanisms by which the innate and adaptive immune systems interact with neurotransmitters and neurocircuits to influence the risk for depression. Here, we detail our current understanding of these pathways and discuss the therapeutic potential of targeting the immune system to treat depression.
Subfields: Behavioral Neuroscience, Biological Psychiatry, Social Psychology
View Paper: https://www.semanticscholar.org/paper/beb88ef66a88ce12f44f857fd516a2bfa59b1022
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Behavioral Neuroscience
- C. Nemeroff
- M. Del Giudice
- Steven W. Gangestad
- Eléonore Beurel
- M. Toups
- J. Cryan
- Ted G. Dinan
- E. Adam
In Biological Psychiatry
- J. Cryan
- Ted G. Dinan
- G. Clarke
- C. Stanton
- R. Stilling
- C. Nemeroff
- M. Del Giudice
- Steven W. Gangestad
In Social Psychology
- J. Cryan
- Ted G. Dinan
- G. Clarke
- M. Del Giudice
- C. Stanton
- Steven W. Gangestad
- R. Stilling
- C. Nemeroff
Citations in the corpus
- Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies (2017, background): “, IL-1b) may convey signals to the brain via afferent nerves like the vagus (2, 4).”
- Diurnal Cortisol Slopes and Mental and Physical Health Outcomes:A Systematic Review and Meta-analysis (2017, background): “Inflammation has been strongly implicated in fatigue and in behavioral withdrawal; elevated inflammation is therefore hypothesized to be one pathway in the development of major depressive disorder (Dantzer et al., 2008; Miller and Raison, 2016).”
- The Bidirectional Relationship of Depression and Inflammation: Double Trouble (2020, background): “Cytokines are one of the most studied components of the immune system in depression (for review, Dantzer et al., 2008; Miller and Raison, 2016; Raison et al., 2006), but little is known about the source and the contribution of cytokines in MDD and their mechanisms of action in the brain.”
- The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020, background): “Furthermore, it has been shown that inflammation biomarkers are increased among patients with depression, and pro-inflammatory cytokines play an important role in the physiopathology of the disease (150).”
- Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. (2018, positive): “Example 3: Depression The link between depression and immunity has become an important theme in biological psychiatry (e.g., Berk et al., 2013; Miller & Raison, 2016).”
- The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? (2016, background): “, 2011) and inflammatory diseases are often associated with depressive symptoms (Miller and Raison, 2016), vice versa, butyrate may also be active in these conditions by reducing inflammation.”